SCIENTIFIC INDUSTRIES INC
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
SCNDStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Shareholders’ Equity
| Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensiveIncome · Accumulated · TotalShareholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | (Loss) | Deficit | Equity | |
| Balance December 31, 2025 | 11,928,599 | $596,400 | $45,039,500 | $178,000 | $(35,150,900) | $10,663,000 |
| Net loss | - | - | - | - | (1,589,300) | (1,589,300) |
| Foreign currency translation adjustment | - | - | - | (74,500) | - | (74,500) |
| Stock-based compensation | - | - | 116,300 | - | - | 116,300 |
| Balance March 31, 2026 | 11,928,599 | $596,400 | $45,155,800 | $103,500 | $(36,740,200) | $9,115,500 |
| Net loss | (1,233,800) | $(1,233,800) | ||||
| Foreign currency translation adjustment | 30,100 | 30,100 | ||||
| Stock-based compensation | 162,500 | 162,500 | ||||
| Balance June 30, 2026 | 11,928,599 | $596,400 | $45,318,300 | $133,600 | $(37,974,000) | $8,074,300 |
| Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensiveIncome · Accumulated · TotalShareholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | (Loss) | Deficit | Equity | |
| Balance December 31, 2024 | 10,503,599 | $525,200 | $42,637,800 | $(113,100) | $(33,930,500) | $9,119,400 |
| Loss from continuing operations | - | - | - | - | (2,057,100) | (2,057,100) |
| Income from discontinued operations | - | - | - | - | 278,600 | 278,600 |
| Foreign currency translation adjustment | - | - | - | 124,400 | - | 124,400 |
| Stock-based compensation | - | - | 302,600 | - | - | 302,600 |
| Balance March 31, 2025 | 10,503,599 | $525,200 | $42,940,400 | $11,300 | $(35,709,000) | $7,767,900 |
| Loss from continuing operations | (1,796,800) | (1,796,800) | ||||
| Income from discontinued operations | 273,100 | 273,100 | ||||
| Issuance of Common Stock and Warrants, net of issuance costs (Note 7) | 1,050,000 | 52,500 | 1,399,700 | 1,452,200 | ||
| Foreign currency translation adjustment | 155,200 | 155,200 | ||||
| Stock-based compensation | 72,600 | 72,600 | ||||
| Balance June 30, 2025 | 11,553,599 | $577,700 | $44,412,700 | $166,500 | $(37,232,700) | $7,924,200 |
See notes to unaudited condensed consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.